Literature DB >> 17172584

vCJD and the gut: implications for endoscopy.

M W Head1, J W Ironside.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17172584      PMCID： PMC1856665          DOI： 10.1136/gut.2006.101964

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  30 in total

1.  High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease.

Authors:  S Joiner; J M Linehan; S Brandner; J D F Wadsworth; J Collinge
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Beyond leukodepletion: removing infectious prions by filtration.

Authors:  Roger P Eglin; William G Murphy
Journal:  Transfusion       Date:  2005-12       Impact factor: 3.157

Review 3.  Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.

Authors:  Christopher A Ludlam; Marc L Turner
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

4.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy.

Authors:  A F Hill; M Zeidler; J Ironside; J Collinge
Journal:  Lancet       Date:  1997-01-11       Impact factor: 79.321

5.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

6.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment.

Authors:  H C Baxter; G A Campbell; A G Whittaker; A C Jones; A Aitken; A H Simpson; M Casey; L Bountiff; L Gibbard; R L Baxter
Journal:  J Gen Virol       Date:  2005-08       Impact factor: 3.891

8.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

Authors:  A F Hill; R J Butterworth; S Joiner; G Jackson; M N Rossor; D J Thomas; A Frosh; N Tolley; J E Bell; M Spencer; A King; S Al-Sarraj; J W Ironside; P L Lantos; J Collinge
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

Review 9.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Risk factors for variant Creutzfeldt-Jakob disease: a case-control study.

Authors:  Hester J T Ward; Dawn Everington; Simon N Cousens; Blaire Smith-Bathgate; Margaret Leitch; Sarah Cooper; Craig Heath; Richard S G Knight; Peter G Smith; Robert G Will
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422
View more
  3 in total

1.  A non-invasive screen for infectivity in transmissible spongiform encephalopathies.

Authors:  D G Glover; B J Pollard; L González; S Sisó; D Kennedy; M Jeffrey
Journal:  Gut       Date:  2007-09       Impact factor: 23.059

2.  Bioassay studies support the potential for iatrogenic transmission of variant Creutzfeldt Jakob Disease through dental procedures.

Authors:  Elizabeth Kirby; Joanne Dickinson; Matthew Vassey; Mike Dennis; Mark Cornwall; Neil McLeod; Andrew Smith; Philip D Marsh; James T Walker; J Mark Sutton; Neil D H Raven
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

3.  Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo.

Authors:  Akihiko Urayama; Luis Concha-Marambio; Uffaf Khan; Javiera Bravo-Alegria; Vineetkumar Kharat; Claudio Soto
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.